| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |